Aegera Therapeutics, Inc.
Records under this name other than patents Aegera Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Aegera Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,645,741 | IAP BIR domain binding compounds Formerly held Lapsed on the fee record Ended Jan 12, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jan 12, 2022 | From the USPTO record |
| US 8,575,113 | BIR domain binding compounds Formerly held Lapsed on the fee record Ended Nov 5, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 5, 2021 | From the USPTO record |
| US 7,579,320 | IAP BIR domain binding compounds Formerly held Lapsed on the fee record Ended Aug 25, 2021 · From the USPTO record | Lapsed on the fee record | Ended Aug 25, 2021 | From the USPTO record |
| US 9,365,614 | IAP BIR domain binding compounds Formerly held Lapsed on the fee record Ended Jun 14, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 14, 2020 | From the USPTO record |
| US 8,163,792 | IAP BIR domain binding compounds Formerly held Lapsed on the fee record Ended Apr 24, 2020 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2020 | From the USPTO record |
| US 7,230,019 | Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides Formerly held Lapsed on the fee record Ended Jun 12, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2019 | From the USPTO record |
| US 6,107,041 | Detection and modulation of IAPS for the diagnosis and treatment of proliferative disease Formerly held Term ended Term ended Dec 16, 2018 · From the USPTO record | Term ended | Term ended Dec 16, 2018 | From the USPTO record |
| US 7,772,177 | BIR domain binding compounds Formerly held Lapsed on the fee record Ended Aug 10, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 10, 2018 | From the USPTO record |
| US 7,772,260 | Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides Formerly held Lapsed on the fee record Ended Aug 10, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 10, 2018 | From the USPTO record |
| US 6,159,709 | XIAP IRES and uses thereof Term ended Term ended Jul 24, 2018 · From the USPTO record | Term ended | Term ended Jul 24, 2018 | From the USPTO record |